Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
Published Jul 1, 2015 · Y. Kuang, Qiuju Chen, Yonglun Fu
Fertility and sterility
295
Citations
19
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayMedroxyprogesterone acetate effectively prevents premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization, without affecting clinical pregnancy rates or embryo cryopreservation.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.